August 22, 2017 9:39 AM ET

Healthcare Equipment and Supplies

Company Overview of TransEnterix, Inc.

Company Overview

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform. In addition, the company develops and manufactures flexible and rigid laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

635 Davis Drive

Suite 300

Morrisville, NC 27560

United States

103 Employees

Phone:

919-765-8400

Fax:

919-765-8459

Key Executives for TransEnterix, Inc.

Chief Executive Officer, President and Director
Age: 52
Total Annual Compensation: $453.2K
Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Age: 52
Total Annual Compensation: $324.5K
COO, CTO & Executive VP
Age: 45
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2016.

TransEnterix, Inc. Key Developments

TransEnterix, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017

TransEnterix, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company reported revenue of $1,584,000, primarily related to the sale of one Senhance during the quarter. Operating loss was $14,792,000 against $80,729,000 a year ago. Loss before income taxes was $15,454,000 against $81,123,000 a year ago. Net loss was $14,713,000 against $80,131,000 a year ago. Net loss per basic and diluted share was $0.11 against $0.70 a year ago. For the six months, the company reported revenue of $3,530,000. Operating loss was $30,670,000 against $95,709,000 a year ago. Loss before income taxes was $31,726,000 against $96,681,000 a year ago. Net loss was $30,127,000 against $93,044,000 a year ago. Net loss per basic and diluted share was $0.24 against $0.85 a year ago. Net cash and cash equivalents used in operating activities was $25,515,000 against $27,826,000 a year ago. Purchase of property and equipment was $1,397,000 against $517,000 a year ago.

TransEnterix, Inc. to Report Q2, 2017 Results on Aug 02, 2017

TransEnterix, Inc. announced that they will report Q2, 2017 results at 5:00 PM, Eastern Standard Time on Aug 02, 2017

TransEnterix, Inc., Q2 2017 Earnings Call, Aug 02, 2017

TransEnterix, Inc., Q2 2017 Earnings Call, Aug 02, 2017

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 10, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TransEnterix, Inc., please visit www.transenterix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.